What is the recommended dose of doxycycline (antibiotic) for sexually transmitted disease (STD) prevention in individuals with high-risk sexual behaviors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxycycline for STD Prevention: Recommended Dosing

The recommended dose of doxycycline for sexually transmitted disease prevention is 200 mg taken as a single dose within 72 hours after condomless oral, vaginal, or anal sex, with a maximum of 200 mg per 24-hour period. 1, 2

Target Population

The CDC specifically recommends doxycycline post-exposure prophylaxis (doxy-PEP) for:

  • Gay, bisexual, and other men who have sex with men (MSM) and transgender women (TGW) who have had at least one bacterial STI (syphilis, chlamydia, or gonorrhea) diagnosed in the past 12 months 1, 2
  • This represents a Strength AI recommendation (strong recommendation, high-quality evidence) from the 2024 CDC guidelines 1
  • Evidence is currently insufficient to recommend for or against doxy-PEP in cisgender women, cisgender heterosexual men, transgender men, and other queer and nonbinary persons 1, 3

Dosing Protocol

Single-dose regimen:

  • 200 mg doxycycline (any formulation) taken once within 72 hours after sexual exposure 1, 2, 4
  • Take as soon as possible after sex, but no later than 72 hours 1
  • Maximum dose: 200 mg per 24 hours, even if multiple sexual encounters occur 1, 2
  • Prescribe enough doses based on anticipated sexual activity until the next visit 2

Expected Efficacy

Doxy-PEP demonstrates significant protective effects:

  • Syphilis and chlamydia: >70% reduction 1, 3
  • Gonorrhea: approximately 50% reduction 1, 3
  • Meta-analysis confirms reduced incidence of first STI (HR 0.538,95% CI 0.337-0.859) and specifically chlamydia (RR 0.291,95% CI 0.093-0.911) 5

Critical Administration Instructions

To prevent esophagitis and optimize absorption:

  • Take with a full glass of water (at least 200 mL) 1, 2
  • Take on a full stomach with non-dairy food 1, 2
  • Remain upright for at least 1 hour after taking the medication 1, 2
  • Separate from dairy products, antacids, calcium, iron, magnesium, or sodium bicarbonate by at least 2 hours before AND after dosing to prevent chelation and treatment failure 2

Monitoring and Follow-up

Reassess every 3-6 months:

  • Perform STI screening at all anatomic sites of exposure (oral, rectal, urogenital) 1, 3
  • Serologic testing for syphilis 1
  • HIV screening per CDC HIV PrEP guidelines 1
  • Assess for doxycycline side effects 1
  • Reassess ongoing need for doxy-PEP 1, 2

Comprehensive Sexual Health Approach

Doxy-PEP should be implemented alongside:

  • Counseling on condom use and partner reduction 1
  • HIV PrEP/PEP as indicated 1
  • Risk reduction counseling at follow-up visits 1

Common Side Effects and Precautions

Counsel patients on:

  • Photosensitivity: Recommend sun protection measures 2, 3
  • Gastrointestinal symptoms: Nausea, vomiting, diarrhea 1, 3
  • Esophagitis risk: Prevented by proper administration technique 1, 3
  • Chronic alcohol consumption may reduce serum doxycycline levels 1

Critical Pitfalls to Avoid

  • Do not exceed 200 mg in 24 hours, even with multiple sexual encounters 1, 2
  • Do not use incorrect dosing: Real-world data shows 21% of users who reported using doxyPEP used a dosage other than the recommended 200 mg 6
  • Do not take with dairy products: This causes chelation and can lead to treatment failure and antimicrobial resistance 2
  • Do not prescribe for populations without evidence: Current data supports use only in MSM and TGW with recent bacterial STI history 1

Antimicrobial Resistance Considerations

  • Ongoing studies are evaluating long-term antimicrobial resistance patterns and population-level impact 1
  • Guidelines will be updated as additional data become available 1
  • Concerns over antimicrobial resistance must be weighed against STI-related morbidity 7

References

Guideline

Doxycycline Prophylaxis Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline Prophylactic Dosing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Doxycycline Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Is a single dose of Doxycycline (Doxycycline) effective for prophylaxis against sexually transmitted infections (STIs)?
What is the proper use of doxycycline (doxy) as post-exposure prophylaxis (PEP) and pre-exposure prophylaxis (PrEP) for individuals engaging in continuous sexual activity for a period of time, such as a week?
Can doxycycline (antibiotic) cure other Sexually Transmitted Diseases (STDs)?
What is the recommended dosage for doxycycline (antibiotic) post-exposure prophylaxis?
What is the role of doxycycline (antibiotic) in HIV (Human Immunodeficiency Virus) post-exposure prophylaxis (PEP) after high-risk intercourse?
What is the diagnosis for a male infant with persistent bleeding after circumcision, with a family history of bleeding disorders in the mother and brother?
What is the best approach to manage pain in a patient with a liver abscess who experienced pain after an attempted insertion of a pigtail (percutaneous catheter)?
How to manage conditions associated with calcium phosphate and brushite in patients at risk of kidney stone disease or disorders of calcium and phosphate metabolism?
What is the assessment and treatment plan for a patient with a neuromuscular disorder, considering their demographic, past medical history, and family history of similar conditions?
What are the possible causes of persistent hypomagnesemia in a patient taking 300 mg magnesium (magnesium) tablets three times a day?
What is the initial evaluation and management approach for a 3-year-old patient presenting with syncope?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.